Source: Annual Congress 2010 - COPD: management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bateman, P. M. A. Calverley, L. M. Fabbri, K. F. Rabe, S. I. Rennard, F. J. Martinez, U. M. Goehring (Cape Town, South Africa; Liverpool, United Kingdom; Modena, Italy; Leiden, Netherlands; Omaha, Ann Arbor, United States Of America; Konstanz, Germany). Efficacy of roflumilast in patients with a history of frequent exacerbations: Pooled data from pivotal 12-month studies. Eur Respir J 2010; 36: Suppl. 54, 4003

Member's Comments

No comment yet.

Related content which might interest you: Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational study Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 The 1-year cost-effectiveness of roflumilast for the treatment of severe to very severe COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 194s Year: 2007 Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Clinical predictors of the effectiveness of tiotropium in adults with symptomatic asthma: the real-life data Source: International Congress 2018 – Tests and trends in asthma Year: 2018 Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis Source: Eur Respir J, 56 (4) 2000151; 10.1183/13993003.00151-2020 Year: 2020 Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study Source: International Congress 2018 – COPD management Year: 2018 Effectiveness of early intervention with budesonide in mild persistent asthma — 5-year data from the START study Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004 Cardiac events among patients with CV comorbidities: Pooled analysis of COPD trials comparing tiotropium with salmeterol Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Exacerbations in a cohort of COPD patients: frequent exacerbators characteristics after 1-year follow-up (EXACO study – interim analysis) Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Characteristics of COPD patients with repeated exacerbations: preliminary results from the PRE-SPIRO survey Source: Annual Congress 2008 - COPD epidemiology Year: 2008 Once-daily NVA237 reduces exacerbations and improves symptoms in COPD patients: A pooled analysis of the GLOW1 and GLOW2 studies Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012 Long-term safety data with once-daily budesonide in mild asthma: results from the START study Source: Eur Respir J 2003; 22: Suppl. 45, 34s Year: 2003 Short-term HRQL deterioration during early-phase COPD exacerbation: a prospective Canadian cohort study Source: Eur Respir J 2005; 26: Suppl. 49, 296s Year: 2005 Lower incidence of asthma exacerbations with FENO-guided anti-inflammatory treatment: A randomised controlled trial Source: Annual Congress 2012 - Effectiveness of respiratory disease management in primary care Year: 2012 Effect of roflumilast on exacerbations in patients with severe COPD and a prior history of hospitalization taking combination therapy Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 COPD patients continuing salmeterol or switched to tiotropium: a retrospective analysis of clinical trial data Source: Eur Respir J 2007; 30: Suppl. 51, 612s Year: 2007 The effect of tiotropium/olodaterol versus tiotropium on COPD exacerbation rates in patients with/without frequent exacerbation history Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019 Patterns, predictors and outcomes of asthma control and exacerbations during pregnancy: a prospective cohort study Source: ERJ Open Res 2016 Year: 2016